Sponsor Pipeline

Anne Louise Tølbøll Sørensen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07474961 BLOOD-dose: A Platform Trial Evaluating Dose Optimization in Hematological Diseases. Waldenstrom Macroglobulinaemia Not Yet Recruiting
Disease Areas
Multiple Myeloma (1)
Get alerts when Anne Louise Tølbøll Sørensen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free